Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Cost-Utility Analysis of rhBMP-2 Use in Adult Spinal Deformity Surgery
Amit Jain
, Samrat Yeramaneni
, Khaled M. Kebaish
, Micheal Raad
, Jeffrey L. Gum
, Eric O. Klineberg
, Hamid Hassanzadeh
, Michael P. Kelly
, Peter G. Passias
, Christopher P. Ames
, Justin S. Smith
, Christopher I. Shaffrey
, Shay Bess
, Virginie Lafage
, Steve Glassman
, Leah Y. Carreon
, Richard A. Hostin
Department of Orthopedic Surgery
Institute of Clinical and Translational Sciences (ICTS)
Division of Spine
Research output
:
Contribution to journal
›
Article
›
peer-review
35
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cost-Utility Analysis of rhBMP-2 Use in Adult Spinal Deformity Surgery'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bone Morphogenetic protein-2 (BMP-2)
100%
Adult Spinal Deformity Surgery
100%
Cost-utility Analysis
100%
Pseudarthrosis
54%
Direct Costs
27%
Quality-adjusted Life Years
18%
Mean Standard Deviation
9%
Reoperation
9%
Revision Surgery
9%
2-year Follow-up
9%
Readmission
9%
Prospective Registry
9%
First-order
9%
Adult Spinal Deformity
9%
Major Complications
9%
Economic Modeling
9%
Decision-analytic Model
9%
Life-years Gained
9%
Cost-utility
9%
Total Direct Costs
9%
Spinal Level
9%
Health Utilities Index
9%
Probabilistic Sensitivity Analysis
9%
SF-6D
9%
One-way Sensitivity Analysis
9%
Second Order Monte Carlo Simulation
9%
Cumulative Quality
9%
Medicine and Dentistry
Health Care Cost
100%
Adult Spine Deformity
100%
Bone Morphogenetic Protein 2
100%
Pseudarthrosis
66%
Quality Adjusted Life Year
22%
Reoperation
11%
Recombinant Bone Morphogenetic Protein 2
11%
Primary Outcome
11%
Monte Carlo Method
11%
Pharmacology, Toxicology and Pharmaceutical Science
Bone Morphogenetic Protein 2
100%
Spine Malformation
100%
Pseudarthrosis
66%
Recombinant Bone Morphogenetic Protein 2
11%